Conclusion: ALA treatment had favorable effects on DSPN by reducing sensory symptoms, and it resulted in a dose-dependent response relative to the placebo for TSS and the global satisfaction score. The use of ALA to prevent neurological symptoms should be further researched.
PubMed 37630823 ↗ALA
Also known as Alpha Lipoic Acid, R-ALA
The short answer. More people than not who report on ALA say it helped (65% of 54). It is most often used for energy: 100% of 15 reports say that improved. It is well studied — 100 meta-analyses on PubMed.
From 320 mentions in total — the rest didn't say how it went and aren't counted.
What ALA does, according to users
Of the people who reported each effect, the share who said it got better.
8 more with fewer than 3 reports
What the research says
Systematic reviews and meta-analyses from PubMed, with their published conclusions.
3+ meta-analyses or systematic reviews and 10+ randomized controlled trials in humans. The grade measures how much human research exists — read the conclusions below for what it found. 100 meta-analyses on PubMed ↗ · 243 randomized trials ↗
Conclusion: A more significant volume in terms of sample size, multi-centres, and multi-arm comparison of therapeutic agents with placebo and longitudinal follow-up studies is recommended to establish a standardised burning mouth syndrome treatment protocol. Further studies are required to assess the analgesic benefits of topical clonazepam and capsaicin, alternative medicines with neurodegenerative prevention capability and psychology support in treating burning mouth syndrome and reducing systemic adverse drug reactions.Registration International Prospective Register of Systematic Reviews (PROSPERO):Pro
PubMed 34404247 ↗Conclusion: Supplementation of some but not all micronutrients may benefit cardiometabolic health. This study highlights the importance of micronutrient diversity and the balance of benefits and risks to promote and maintain cardiovascular health in diverse populations. (Antioxidant Supplementation in the Prevention and Treatment of Cardiovascular Diseases; CRD42022315165).
PubMed 36480969 ↗Conclusion: Our analysis suggests that ALA probably has little or no effect on neuropathy symptoms or adverse events at six months, and may have little or no effect on impairment at six months. All the studies were at high risk of attrition bias. Therefore, future RCTs should ensure complete follow-up and transparent reporting of any participants missing from the analyses.
PubMed 38205823 ↗238 human trials on ClinicalTrials.gov test ALA — 149 completed, 16 recruiting now. See all on ClinicalTrials.gov ↗
- A Study to Assess Effect of Glucocil® on Metabolic Health in Individuals With Prediabetes and Type 2 Diabetes Mellitus. · Pre Diabetes, Type2 Diabetes Mellitus · 2025
- Alpha Lipoic Acid in Ulcerative Colitis · Ulcerative Colitis, Ulcerative Colitis (UC) · 2025
- Effect of ALA Combined With Letrozole on Polycystic Ovary Syndrome Clinical Outcome in Infertile Females · Polycystic Ovary Syndrome, Infertility, Female · 2025
Reports to the FDA
Adverse-event reports about supplements containing it, submitted to the US FDA by consumers and doctors.
90 reports name a product containing ALA (2004–2025); 34 involved hospitalization or worse. Most often reported:
- Dyspnoea · 8
- Palpitations · 7
- Fatigue · 7
- Diarrhoea · 7
- Dyspepsia · 6
- Hypersensitivity · 6
A report doesn't prove the supplement caused the problem — many products contain several ingredients, and these counts can't tell you how often it happens. Source: FDA CAERS ↗ · raw reports (openFDA) ↗.
What government agencies say
Official records from US, Canadian and EU regulators, each linked to its source.
1 recall of products named for ALA. Most recent:
- 2013-05-01 · Class III: Nexgen Pharma is recalling a certain lot of dietary supplement L-Arginine L-Ornithine Alpha Lipoic Acid Capsules due to subpotency of the Alpha Lipoic Acid… record ↗
Class I = could cause serious harm; Class II = temporary or reversible harm; Class III = unlikely to cause harm. Recalls are of specific products and lots, not of the ingredient itself. All recalls (openFDA) ↗
LiverTox rates ALA E — an unlikely cause of liver injury. LiverTox entry ↗
- Source of (an) antioxidant(s)/Provides (an) antioxidant(s).
- Source of (an) antioxidant(s)/Provides (an) antioxidant(s) that help(s) fight/protect (cell) against/reduce (the oxidative effect of/the oxidative damage caused by/cell damage caused by) free radicals.
- Helps to promote healthy glucose metabolism.
Required cautions: Ask a health care practitioner before use if you are pregnant or breastfeeding. Ask a health care practitioner before use if you have diabetes. Stop use and ask a health care practitioner if you experience sweating, paleness, chills, headache, dizziness and/or confusion (as these may be symptoms of serious low blood sugar).
No health claim for ALA is authorised in the EU.
6 proposed claims were rejected, usually because EFSA found the evidence insufficient (example ↗).
NIH has funded 12 research projects with ALA in the title, $2,280,980 in total (2003–2026). NIH RePORTER ↗
Dosage people report
As stated by users — not a recommendation. Follow the label or your doctor.
Reported side effects
How often each side effect came up across all reports.
What users say
First-hand experiences, quoted verbatim. We show one positive and one negative where both exist.
“I also take alcar, alpha lipoic acid, choline, and pqq, but... there is some difference with these, but not as major as with CoQ10.”
“ALCAR+alpha lipoic acid works as well as Adderall. Actually, it's a bit better for me—it wears off more slowly and doesn't interfere with sleep the way Adderall does.”
“ALA fixed the issue almost instantly, so I usually don't take ALCAR without the ALA.”
“R-ALA - has shrunk keloids that I was told would never go away and helped with general over all MS body pain”
Top discussions (5)
- Rhonda Patrick's Supplement Stack ↗
- This is gonna be an unpopular post but figured I’d get the best answers here ↗
- Basic supplements to boost cognitive performance ↗
- This is a before and after… 7 months on Reta, BPC157, TB500, Tesa, MOTS-C, GHK-cu, Selank, Semax, and TRT, along with an intense diet. Down 110lbs. 48” waist to 27”. ↗
- MDMA Biohacking Advice Needed: Second Time Taking, Looking to Maximize Enjoyment and Minimize Comedown ↗
ALA compared
Other options for energy
Sources
- User reports: 320 mentions in public discussions, quoted with a link to each discussion (e.g. this thread ↗).
- PubMed (US National Library of Medicine, NIH): meta-analyses ↗ · randomized trials ↗
- ClinicalTrials.gov (NIH): registered trials ↗
- FDA recalls ↗
- LiverTox (NIH) ↗
- NIH RePORTER ↗
- Health Canada ↗
- EU health-claims register ↗
- US Food and Drug Administration: CAERS adverse-event reports ↗
User data from public discussions; research from PubMed. Information only, not medical advice — talk to a doctor before starting, stopping or combining anything. Data updated October 5, 2026. How we rate